150 related articles for article (PubMed ID: 11062899)
1. [Approaches in diabetes therapy. 2. Selection and use of oral antidiabetics. 1) Drugs enhancing insulin secretion].
Yoshimoto K; Ishida H
Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1523-9. PubMed ID: 11062899
[No Abstract] [Full Text] [Related]
2. [Proper selection and practical administration of sulphonylurea agents to diabetics].
Kurahachi H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():346-50. PubMed ID: 12387016
[No Abstract] [Full Text] [Related]
3. [Pharmacologic profile of oral antidiabetic agents].
Okubo M; Yamane K; Kohno N
Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
[No Abstract] [Full Text] [Related]
4. Type 2 diabetes and insulin secretagogues.
Hormone Foundation
J Clin Endocrinol Metab; 2012 Mar; 97(3):37A-38A. PubMed ID: 22392961
[No Abstract] [Full Text] [Related]
5. Insulin responses to sulfonylureas.
Cerasi E
Diabetes Res Clin Pract; 2002 Apr; 56(1):69-70; author reply 71. PubMed ID: 11879723
[No Abstract] [Full Text] [Related]
6. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part I--"The pros".
Waldhäusl W
Horm Metab Res; 1996 Sep; 28(9):517-21. PubMed ID: 8911990
[No Abstract] [Full Text] [Related]
7. [Differences between oral antidiabetics].
Bleskestad IH; Birkeland KI
Tidsskr Nor Laegeforen; 2003 Mar; 123(6):808-9. PubMed ID: 12693123
[No Abstract] [Full Text] [Related]
8. [Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
Tatoń J; Koliński P
Pol Tyg Lek; 1985 May; 40(18):505-11. PubMed ID: 3892513
[No Abstract] [Full Text] [Related]
9. Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management.
Pontiroli AE; Calderara A; Pozza G
Diabetes Metab Rev; 1994 Apr; 10(1):31-43. PubMed ID: 7956674
[No Abstract] [Full Text] [Related]
10. Does insulin preserve beta-cell function in type 2 diabetes?
Heise T; Sawicki PT
J Intern Med; 2002 Apr; 251(4):283-5. PubMed ID: 11952878
[No Abstract] [Full Text] [Related]
11. [Sulfonylurea and alpha-glucosidase inhibitor].
Iijima T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():459-63. PubMed ID: 12387034
[No Abstract] [Full Text] [Related]
12. Oral hypoglycemic agents.
Boyden T; Bressler R
Adv Intern Med; 1979; 24():53-70. PubMed ID: 371368
[No Abstract] [Full Text] [Related]
13. [Clinical utilization of combined rosiglitazone and glimepiride in the treatment of type 2 diabetes mellitus].
Fehér J; Lengyel G
Orv Hetil; 2007 Dec; 148(49):2331-5. PubMed ID: 18048112
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy of glimepiride].
Kaneko T; Sakamoto N
Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
[No Abstract] [Full Text] [Related]
15. [Which treatment can be proposed to a diabetic patient presenting with secondary failure of oral antidiabetics?].
Blanc MH; Galtier-Dereure F; Parer-Richard C; Bringer J; Jaffiol C
Rev Med Suisse Romande; 1993 Nov; 113(11):955-61. PubMed ID: 8272722
[No Abstract] [Full Text] [Related]
16. New pharmacologic approaches to the treatment of diabetes.
Johnson DG; Bressler R
Spec Top Endocrinol Metab; 1984; 6():163-92. PubMed ID: 6151747
[No Abstract] [Full Text] [Related]
17. Timely addition of insulin to oral therapy for type 2 diabetes.
Riddle MC
Diabetes Care; 2002 Feb; 25(2):395-6. PubMed ID: 11815517
[No Abstract] [Full Text] [Related]
18. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
Takamatsu J
Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
[No Abstract] [Full Text] [Related]
19. Insulin initiation in Type 2 diabetes.
Page S
Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
[No Abstract] [Full Text] [Related]
20. [Drug therapy of diabetes mellitus].
Kaneko T
Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):406-9. PubMed ID: 8315336
[No Abstract] [Full Text] [Related]
[Next] [New Search]
